サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1539327

グリコバイオロジー市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2033年

Glycobiology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 246 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
グリコバイオロジー市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2033年
出版日: 2024年08月19日
発行: Persistence Market Research
ページ情報: 英文 246 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社はこのほど、世界のグリコバイオロジー市場に関する詳細な調査レポートを発行しました。当レポートでは、市場促進要因・動向・機会・課題などの主要な市場力学を詳細に分析し、市場構造に関する深い洞察を提供しています。

主な洞察

  • グリコバイオロジー市場規模（2024E）：17億米ドル
  • 予測市場価値（2033F）：54億米ドル
  • 世界市場成長率（CAGR 2024年から2033年まで）：13.7%

グリコバイオロジー市場- レポート範囲：

グリコバイオロジー市場は、生体システムにおける糖鎖（グリカン）の構造、機能、生物学に関する研究および分析を含みます。グリコバイオロジーは、細胞シグナル伝達、免疫応答、疾病の進行など、様々な生物学的プロセスを理解する上で重要な役割を果たしています。市場は、創薬・薬剤開発、診断学、腫瘍学、免疫学など、用途別に細分化されています。成長の原動力は、グライコミクスにおける研究活動の増加、個別化医療に対する需要の高まり、グリカン分析技術の進歩です。

市場成長の促進要因：

世界のグリコバイオロジー市場を牽引している主な要因はいくつかあります。バイオ医薬品の研究開発への注目の高まり、創薬や疾病診断におけるグリコバイオロジーの応用の増加は、主要な成長促進要因です。質量分析とクロマトグラフィー技術の進歩は、より正確で効率的な糖鎖分析を可能にすることで、市場の拡大に拍車をかけています。さらに、がんや糖尿病などの慢性疾患の有病率の増加は、標的治療法の開発におけるグリコバイオロジーの重要性を強調し、市場の成長を後押ししています。疾患の早期発見における糖鎖バイオマーカーの利用拡大や、治療用途での糖鎖工学への関心の高まりも、市場の成長に大きく寄与しています。

市場抑制要因：

有望な成長見通しにもかかわらず、グリコバイオロジー市場は、糖鎖分析の複雑さと高度なグリコバイオロジー研究ツールに関連する高コストに関連する課題に直面しています。標準化されたプロトコルがなく、糖鎖分析の専門知識が必要なため、小規模な研究機関ではグリコバイオロジー技術の採用が制限される可能性があり、市場の成長が妨げられる可能性があります。さらに、臨床診療へのグリコバイオロジーの統合はまだ初期段階にあり、研究結果を治療応用に結びつける上での課題となっています。これらの問題に対処するには、トレーニングと教育への継続的な投資と、より広範な研究者や臨床医がグリコバイオロジーをより利用しやすくするための費用対効果の高いツールや技術の開発が必要です。

市場機会：

この市場は、糖鎖ベースの診断法の採用の増加と、革新的な治療ソリューションに対する需要の高まりにより、大きな機会をもたらしています。より高い感度と特異性を備えた次世代糖鎖分析ツールの開発は、精密医療に対するニーズの高まりに対応しています。新興経済国での研究活動の拡大、学術機関とバイオ医薬品企業との連携の増加は、市場成長の新たなチャネルを提供し、疾病治療および予防におけるグリコバイオロジーの新規アプリケーションの探求を可能にします。戦略的パートナーシップ、最先端技術への投資、および糖鎖ベースの個別化医療のイントロダクションは、新たな機会を活用し、市場のリーダーシップを維持するために不可欠です。

本レポートで扱う主な質問

  • 世界のグリコバイオロジー市場の成長を促進する主な要因は何か？
  • グリコバイオロジーのどの種類と用途が様々な分野での採用をリードしているか？
  • 技術進歩はグリコバイオロジー市場の競合情勢にどのような影響を与えているか？
  • グリコバイオロジー市場の主要プレーヤーは誰で、競争力を維持するためにどのような戦略を採用しているのか？
  • 世界のグリコバイオロジー市場の新たな動向と将来展望は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主な動向
  • 製品イノベーション/開発動向

第4章 重要成功要因

  • 製品の採用/使用状況分析
  • 製品のUSP/特徴
  • 最近の製品承認と発売
  • PESTLE分析
  • ポーターの分析
  • 規制シナリオ
  • バリューチェーン分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • ダイナミクス

第6章 COVID-19危機- 影響評価

  • COVID-19と影響分析
    • 製品別
    • 酵素別
    • アプリケーション別
    • エンドユーザー別
    • 地域別
  • 2024年の市場シナリオ

第7章 世界市場の需要（金額および規模）分析

  • 市場（金額）分析、2019～2023年
  • 市場（金額）予測、2024～2033年
    • 前年比成長動向分析
    • 絶対的収益機会

第8章 製品別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）分析と予測、2024～2033年
    • 機器
    • 酵素
    • 消耗品
    • キットと試薬
  • 製品別市場の魅力分析

第9章 酵素別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）分析と予測、2024～2033年
    • ガラクトシダーゼ
      • フコシダーゼ
      • キチナーゼ
      • アセチルガラクトサミニダーゼ
      • ヘパリナーゼ
      • PNGアーゼF
      • その他
    • GlcNAcトランスフェラーゼ
      • アセチルグルコサミニルトランスフェラーゼ
      • エキソストシン
      • その他
    • フコシルトランスフェラーゼ
    • GalNAcトランスフェラーゼ
    • ガラクトシルトランスフェラーゼ
    • グルクロン酸転移酵素
    • グルコシルトランスフェラーゼ
    • ペントシルトランスフェラーゼ
    • 炭水化物キナーゼ
    • ノイラミニダーゼ
    • シアリルトランスフェラーゼ
    • その他
  • 酵素別市場の魅力分析

第10章 アプリケーション別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）分析と予測、2024～2033年
    • 医薬品の発見と開発
    • 診断アプリケーション
      • 腫瘍学
      • 免疫学
      • その他
    • 産業用途
    • 治療用途
      • 腫瘍学
      • 免疫学
      • その他
    • その他
  • アプリケーション別の市場の魅力分析

第11章 エンドユーザー別世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）分析と予測、2024～2033年
    • バイオ医薬品企業
    • ラボ
    • 病院
    • 診断センター
    • 受託研究機関
    • バイオテクノロジー産業
    • 学術機関
    • その他
  • エンドユーザー別市場の魅力分析

第12章 地域別：世界市場分析

  • イントロダクション
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）分析と予測、2024～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 南アジア
    • 東アジア
    • オセアニア
    • 中東およびアフリカ（中東・アフリカ）
  • 地域別市場の魅力分析

第13章 北米市場分析

第14章 ラテンアメリカ市場分析

第15章 欧州市場分析

第16章 南アジア市場分析

第17章 東アジア市場分析

第18章 オセアニア市場分析

第19章 中東・アフリカ市場分析

第20章 市場構造分析

  • 企業階層別市場分析
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第21章 競合分析

  • 競合ダッシュボード
  • ブランディングとプロモーション戦略
  • 主要開発分析
  • 競合の詳細
    • Glycodiag
    • Tracxn Technologies Limited
    • Agilent Tecnologies, Inc.
    • Takara Bio Inc.
    • Bio-Techne
    • Bruker Corporation
    • Thermo Fisher Scientific Inc.
    • Shimadzu Corporation
    • New England Biolabs.
    • Waters.co.
    • Merck KGaA
    • Palleon Pharmaceuticals
    • Asparia Glycomics
    • RayBiotech Life,Inc.
    • Z Biotech,LLC.
    • Chemily Glycoscience
    • Lectenz Bio
    • 2BScientific

第22章 使用される前提条件と頭字語

第23章 調査手法

目次
Product Code: PMRREP4769

Persistence Market Research has recently published an in-depth report on the global Glycobiology Market. This report provides a detailed analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, offering deep insights into the market structure.

Key Insights:

  • Glycobiology Market Size (2024E): USD 1.7 Bn
  • Projected Market Value (2033F): USD 5.4 Bn
  • Global Market Growth Rate (CAGR 2024 to 2033): 13.7%

Glycobiology Market - Report Scope:

The Glycobiology Market involves the study and analysis of the structure, function, and biology of carbohydrates (glycans) in biological systems. Glycobiology plays a crucial role in understanding various biological processes, including cell signaling, immune response, and disease progression. The market is segmented by application, including drug discovery and development, diagnostics, oncology, and immunology, among others. Growth is driven by increasing research activities in glycomics, the rising demand for personalized medicine, and advancements in glycan analysis technologies.

Market Growth Drivers:

Several key factors are driving the global Glycobiology Market. The rising focus on research and development in biopharmaceuticals and the increasing application of glycobiology in drug discovery and disease diagnosis are major growth drivers. The ongoing advancements in mass spectrometry and chromatography technologies further fuel market expansion by enabling more accurate and efficient glycan analysis. Additionally, the growing prevalence of chronic diseases, such as cancer and diabetes, underscores the importance of glycobiology in developing targeted therapies, thereby boosting market growth. The expanding use of glycan biomarkers in early disease detection and the growing interest in glyco-engineering for therapeutic applications also contribute significantly to the market's growth.

Market Restraints:

Despite the promising growth prospects, the Glycobiology Market faces challenges related to the complexity of glycan analysis and the high costs associated with advanced glycobiology research tools. The market growth may be hindered by the lack of standardized protocols and the need for specialized expertise in glycan analysis, which can limit the adoption of glycobiology technologies in smaller research institutions. Additionally, the integration of glycobiology into clinical practice is still in its nascent stages, posing challenges in translating research findings into therapeutic applications. Addressing these issues requires ongoing investment in training and education, as well as the development of cost-effective tools and techniques to make glycobiology more accessible to a broader range of researchers and clinicians.

Market Opportunities:

The market presents significant opportunities driven by the increasing adoption of glycan-based diagnostics and the rising demand for innovative therapeutic solutions. The development of next-generation glycan analysis tools with higher sensitivity and specificity caters to the growing need for precision medicine. The expansion of research activities in emerging economies and the increasing collaboration between academic institutions and biopharmaceutical companies provide new channels for market growth, allowing for the exploration of novel applications of glycobiology in disease treatment and prevention. Strategic partnerships, investments in cutting-edge technologies, and the introduction of glycan-based personalized medicine are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Glycobiology Market globally?
  • Which types and applications of glycobiology are leading the adoption in various sectors?
  • How are technological advancements influencing the competitive landscape of the Glycobiology Market?
  • Who are the key players in the Glycobiology Market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Glycobiology Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Glycobiology Market, including Thermo Fisher Scientific, Agilent Technologies, and Merck KGaA, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest heavily in R&D to develop advanced glycobiology tools and explore new applications in drug development and diagnostics. Collaborations with academic institutions, research organizations, and biotechnology firms facilitate market access and promote the adoption of new technologies. Emphasis on customer education, high-quality products, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving Glycobiology Market landscape.

Key Companies Profiled:

  • Glycodiag
  • Tracxn Technologies Limited
  • Agilent Tecnologies, Inc.
  • Takara Bio Inc.
  • Bio-Techne
  • Bruker Corporation
  • Thermo Fisher Scientific Inc.
  • Shimadzu Corporation
  • New England Biolabs.
  • Waters.co.
  • Merck KGaA
  • Palleon Pharmaceuticals
  • Asparia Glycomics
  • RayBiotech Life,Inc.
  • Z Biotech,LLC.
  • Chemily Glycoscience
  • Lectenz Bio
  • 2BScientific

Glycobiology Market Industry Segmentation

Product:

  • Instruments
  • Enzymes
  • Consumables
  • Kits and Reagents

By Enzyme:

  • Galactosidases
  • GlcNAc Transferases
  • Fucosyltransferases
  • GalNAc Transferases
  • Galactosyl Transferases
  • Glucuronosyltransferases
  • Glucosyltransferases
  • Pentosyltransferases
  • Carbohydrate Kinases
  • Neuraminidases
  • Sialyltransferases
  • Others

Application:

  • Drug Discovery and Development
  • Diagnostic Applications
  • Industrial Applications
  • Therapeutic Applications
  • Others

End User:

  • Biopharmaceutical Companies
  • Research Laboratories
  • Hospitals
  • Diagnostic Centers
  • Contract Research Organizations
  • Biotechnology Industries
  • Academic Institutes
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features
  • 4.3. Recent Product Approval and Launches
  • 4.4. PESTLE Analysis
  • 4.5. Porter's Analysis
  • 4.6. Regulatory Scenario
  • 4.7. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure Outlook
    • 5.1.3. Global Enzymes Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Rising Geriatric Population
    • 5.2.2. Funding Through Government Bodies
    • 5.2.3. Technological Advancements
    • 5.2.4. Mergers and Acquisitions
    • 5.2.5. Cost of Glycobiology Products
    • 5.2.6. Increasing Incidence of Congenital Disorders
    • 5.2.7. Growing Investments in Precision Medicine Development
  • 5.3. Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Enzyme
    • 6.1.3. By Application
    • 6.1.4. By End User
    • 6.1.5. By Region
  • 6.2. 2024 Market Scenario

7. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) Analysis By Product, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product, 2024-2033
    • 8.3.1. Instruments
    • 8.3.2. Enzymes
    • 8.3.3. Consumables
    • 8.3.4. Kits and Reagents
  • 8.4. Market Attractiveness Analysis By Product

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Enzyme

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis By Enzyme, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Enzyme, 2024-2033
    • 9.3.1. Galactosidases
      • 9.3.1.1. Fucosidases
      • 9.3.1.2. Chitinases
      • 9.3.1.3. Acetylgalactosaminidase
      • 9.3.1.4. Heparinase
      • 9.3.1.5. PNGase F
      • 9.3.1.6. Others
    • 9.3.2. GlcNAc Transferases
      • 9.3.2.1. Acetylglucosaminyltransferase
      • 9.3.2.2. Exostosin
      • 9.3.2.3. Others
    • 9.3.3. Fucosyltransferases
    • 9.3.4. GalNAc Transferases
    • 9.3.5. Galactosyl Transferases
    • 9.3.6. Glucuronosyltransferases
    • 9.3.7. Glucosyltransferases
    • 9.3.8. Pentosyltransferases
    • 9.3.9. Carbohydrate Kinases
    • 9.3.10. Neuraminidases
    • 9.3.11. Sialyltransferases
    • 9.3.12. Others
  • 9.4. Market Attractiveness Analysis By Enzyme

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2024-2033
    • 10.3.1. Drug Discovery and Development
    • 10.3.2. Diagnostic Applications
      • 10.3.2.1. Oncology
      • 10.3.2.2. Immunology
      • 10.3.2.3. Others
    • 10.3.3. Industrial Applications
    • 10.3.4. Therapeutic Applications
      • 10.3.4.1. Oncology
      • 10.3.4.2. Immunology
      • 10.3.4.3. Others
    • 10.3.5. Others
  • 10.4. Market Attractiveness Analysis By Application

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
    • 11.3.1. Biopharmaceutical Companies
    • 11.3.2. Research Laboratories
    • 11.3.3. Hospitals
    • 11.3.4. Diagnostic Centres
    • 11.3.5. Contract Research Organizations
    • 11.3.6. Biotechnology Industries
    • 11.3.7. Academic Institutes
    • 11.3.8. Others
  • 11.4. Market Attractiveness Analysis By End User

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. South Asia
    • 12.3.5. East Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East and Africa (MEA)
  • 12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
    • 13.3.2. By Product
    • 13.3.3. By Enzyme
    • 13.3.4. By Application
    • 13.3.5. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Enzyme
    • 13.4.4. By Application
    • 13.4.5. By End User
  • 13.5. Country Level Analysis & Forecast
    • 13.5.1. U.S. Market Analysis
      • 13.5.1.1. Introduction
      • 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.1.2.1. By Product
        • 13.5.1.2.2. By Enzyme
        • 13.5.1.2.3. By Application
        • 13.5.1.2.4. By End User
    • 13.5.2. Canada Market Analysis
      • 13.5.2.1. Introduction
      • 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.2.2.1. By Product
        • 13.5.2.2.2. By Enzyme
        • 13.5.2.2.3. By Application
        • 13.5.2.2.4. By End User
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Brazil
      • 14.3.1.2. Mexico
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
    • 14.3.2. By Enzyme
    • 14.3.3. By Application
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Enzyme
    • 14.4.4. By Application
    • 14.4.5. By End User
  • 14.5. Country Level Analysis & Forecast
    • 14.5.1. Brazil Market Analysis
      • 14.5.1.1. Introduction
      • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.1.2.1. By Product
        • 14.5.1.2.2. By Enzyme
        • 14.5.1.2.3. By Application
        • 14.5.1.2.4. By End User
    • 14.5.2. Mexico Market Analysis
      • 14.5.2.1. Introduction
      • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.2.2.1. By Product
        • 14.5.2.2.2. By Enzyme
        • 14.5.2.2.3. By Application
        • 14.5.2.2.4. By End User
    • 14.5.3. Argentina Market Analysis
      • 14.5.3.1. Introduction
      • 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.3.2.1. By Product
        • 14.5.3.2.2. By Enzyme
        • 14.5.3.2.3. By Application
        • 14.5.3.2.4. By End User
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Germany
      • 15.3.1.2. France
      • 15.3.1.3. Italy
      • 15.3.1.4. U.K.
      • 15.3.1.5. Spain
      • 15.3.1.6. Russia
      • 15.3.1.7. BENELUX
      • 15.3.1.8. Nordic Countries
      • 15.3.1.9. Rest of Europe
    • 15.3.2. By Product
    • 15.3.3. By Enzyme
    • 15.3.4. By Application
    • 15.3.5. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Enzyme
    • 15.4.4. By Application
    • 15.4.5. By End User
  • 15.5. Country Level Analysis & Forecast
    • 15.5.1. Germany Market Analysis
      • 15.5.1.1. Introduction
      • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.1.2.1. By Product
        • 15.5.1.2.2. By Enzyme
        • 15.5.1.2.3. By Application
        • 15.5.1.2.4. By End User
    • 15.5.2. France Market Analysis
      • 15.5.2.1. Introduction
      • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.2.2.1. By Product
        • 15.5.2.2.2. By Enzyme
        • 15.5.2.2.3. By Application
        • 15.5.2.2.4. By End User
    • 15.5.3. Italy Market Analysis
      • 15.5.3.1. Introduction
      • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.3.2.1. By Product
        • 15.5.3.2.2. By Enzyme
        • 15.5.3.2.3. By Application
        • 15.5.3.2.4. By End User
    • 15.5.4. U.K. Market Analysis
      • 15.5.4.1. Introduction
      • 15.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.4.2.1. By Product
        • 15.5.4.2.2. By Enzyme
        • 15.5.4.2.3. By Application
        • 15.5.4.2.4. By End User
    • 15.5.5. Spain Market Analysis
      • 15.5.5.1. Introduction
      • 15.5.5.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.5.2.1. By Product
        • 15.5.5.2.2. By Enzyme
        • 15.5.5.2.3. By Application
        • 15.5.5.2.4. By End User
    • 15.5.6. Russia Market Analysis
      • 15.5.6.1. Introduction
      • 15.5.6.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.6.2.1. By Product
        • 15.5.6.2.2. By Enzyme
        • 15.5.6.2.3. By Application
        • 15.5.6.2.4. By End User
    • 15.5.7. Nordic Countries Market Analysis
      • 15.5.7.1. Introduction
      • 15.5.7.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.7.2.1. By Product
        • 15.5.7.2.2. By Enzyme
        • 15.5.7.2.3. By Application
        • 15.5.7.2.4. By End User
    • 15.5.8. BENELUX Market Analysis
      • 15.5.8.1. Introduction
      • 15.5.8.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.8.2.1. By Product
        • 15.5.8.2.2. By Enzyme
        • 15.5.8.2.3. By Application
        • 15.5.8.2.4. By End User
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis

16. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Thailand
      • 16.3.1.3. Indonesia
      • 16.3.1.4. Malaysia
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Product
    • 16.3.3. By Enzyme
    • 16.3.4. By Application
    • 16.3.5. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Enzyme
    • 16.4.4. By Application
    • 16.4.5. By End User
  • 16.5. Country Level Analysis & Forecast
    • 16.5.1. India Market Analysis
      • 16.5.1.1. Introduction
      • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.1.2.1. By Product
        • 16.5.1.2.2. By Enzyme
        • 16.5.1.2.3. By Application
        • 16.5.1.2.4. By End User
    • 16.5.2. Thailand Market Analysis
      • 16.5.2.1. Introduction
      • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.2.2.1. By Product
        • 16.5.2.2.2. By Enzyme
        • 16.5.2.2.3. By Application
        • 16.5.2.2.4. By End User
    • 16.5.3. Indonesia Market Analysis
      • 16.5.3.1. Introduction
      • 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.3.2.1. By Product
        • 16.5.3.2.2. By Enzyme
        • 16.5.3.2.3. By Application
        • 16.5.3.2.4. By End User
    • 16.5.4. Malaysia Market Analysis
      • 16.5.4.1. Introduction
      • 16.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.4.2.1. By Product
        • 16.5.4.2.2. By Enzyme
        • 16.5.4.2.3. By Application
        • 16.5.4.2.4. By End User
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Product
    • 17.3.3. By Enzyme
    • 17.3.4. By Application
    • 17.3.5. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Enzyme
    • 17.4.4. By Application
    • 17.4.5. By End User
  • 17.5. Country Level Analysis & Forecast
    • 17.5.1. China Market Analysis
      • 17.5.1.1. Introduction
      • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.1.2.1. By Product
        • 17.5.1.2.2. By Enzyme
        • 17.5.1.2.3. By Application
        • 17.5.1.2.4. By End User
    • 17.5.2. Japan Market Analysis
      • 17.5.2.1. Introduction
      • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.2.2.1. By Product
        • 17.5.2.2.2. By Enzyme
        • 17.5.2.2.3. By Application
        • 17.5.2.2.4. By End User
    • 17.5.3. South Korea Market Analysis
      • 17.5.3.1. Introduction
      • 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.3.2.1. By Product
        • 17.5.3.2.2. By Enzyme
        • 17.5.3.2.3. By Application
        • 17.5.3.2.4. By End User
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
    • 18.3.2. By Product
    • 18.3.3. By Enzyme
    • 18.3.4. By Application
    • 18.3.5. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Enzyme
    • 18.4.4. By Application
    • 18.4.5. By End User
  • 18.5. Country Level Analysis & Forecast
    • 18.5.1. Australia Market Analysis
      • 18.5.1.1. Introduction
      • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.1.2.1. By Product
        • 18.5.1.2.2. By Enzyme
        • 18.5.1.2.3. By Application
        • 18.5.1.2.4. By End User
    • 18.5.2. New Zealand Market Analysis
      • 18.5.2.1. Introduction
      • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.2.2.1. By Product
        • 18.5.2.2.2. By Enzyme
        • 18.5.2.2.3. By Application
        • 18.5.2.2.4. By End User
  • 18.6. Market Trends
  • 18.7. Key Market Participants - Intensity Mapping
  • 18.8. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkiye
      • 19.3.1.3. Northern Africa
      • 19.3.1.4. South Africa
      • 19.3.1.5. Rest of Middle East and Africa
    • 19.3.2. By Product
    • 19.3.3. By Enzyme
    • 19.3.4. By Application
    • 19.3.5. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Enzyme
    • 19.4.4. By Application
    • 19.4.5. By End User
  • 19.5. Country Level Analysis & Forecast
    • 19.5.1. GCC Countries Market Analysis
      • 19.5.1.1. Introduction
      • 19.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.1.2.1. By Product
        • 19.5.1.2.2. By Enzyme
        • 19.5.1.2.3. By Application
        • 19.5.1.2.4. By End User
    • 19.5.2. Turkiye Market Analysis
      • 19.5.2.1. Introduction
      • 19.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.2.2.1. By Product
        • 19.5.2.2.2. By Enzyme
        • 19.5.2.2.3. By Application
        • 19.5.2.2.4. By End User
    • 19.5.3. Northern Africa Market Analysis
      • 19.5.3.1. Introduction
      • 19.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.3.2.1. By Product
        • 19.5.3.2.2. By Enzyme
        • 19.5.3.2.3. By Application
        • 19.5.3.2.4. By End User
    • 19.5.4. South Africa Market Analysis
      • 19.5.4.1. Introduction
      • 19.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.4.2.1. By Product
        • 19.5.4.2.2. By Enzyme
        • 19.5.4.2.3. By Application
        • 19.5.4.2.4. By End User
  • 19.6. Market Trends
  • 19.7. Key Market Participants - Intensity Mapping
  • 19.8. Drivers and Restraints - Impact Analysis

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Share Analysis of Top Players
  • 20.3. Market Presence Analysis

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Branding and Promotional Strategies
  • 21.3. Key Development Analysis
  • 21.4. Competition Deep Dive
    • 21.4.1. Glycodiag
      • 21.4.1.1. Overview
      • 21.4.1.2. Product Portfolio
      • 21.4.1.3. Key Financials
      • 21.4.1.4. Sales Footprint
      • 21.4.1.5. SWOT Analysis
      • 21.4.1.6. Strategy Overview
    • 21.4.2. Tracxn Technologies Limited
      • 21.4.2.1. Overview
      • 21.4.2.2. Product Portfolio
      • 21.4.2.3. Key Financials
      • 21.4.2.4. Sales Footprint
      • 21.4.2.5. SWOT Analysis
      • 21.4.2.6. Strategy Overview
    • 21.4.3. Agilent Tecnologies, Inc.
      • 21.4.3.1. Overview
      • 21.4.3.2. Product Portfolio
      • 21.4.3.3. Key Financials
      • 21.4.3.4. Sales Footprint
      • 21.4.3.5. SWOT Analysis
      • 21.4.3.6. Strategy Overview
    • 21.4.4. Takara Bio Inc.
      • 21.4.4.1. Overview
      • 21.4.4.2. Product Portfolio
      • 21.4.4.3. Key Financials
      • 21.4.4.4. Sales Footprint
      • 21.4.4.5. SWOT Analysis
      • 21.4.4.6. Strategy Overview
    • 21.4.5. Bio-Techne
      • 21.4.5.1. Overview
      • 21.4.5.2. Product Portfolio
      • 21.4.5.3. Key Financials
      • 21.4.5.4. Sales Footprint
      • 21.4.5.5. SWOT Analysis
      • 21.4.5.6. Strategy Overview
    • 21.4.6. Bruker Corporation
      • 21.4.6.1. Overview
      • 21.4.6.2. Product Portfolio
      • 21.4.6.3. Key Financials
      • 21.4.6.4. Sales Footprint
      • 21.4.6.5. SWOT Analysis
      • 21.4.6.6. Strategy Overview
    • 21.4.7. Thermo Fisher Scientific Inc.
      • 21.4.7.1. Overview
      • 21.4.7.2. Product Portfolio
      • 21.4.7.3. Key Financials
      • 21.4.7.4. Sales Footprint
      • 21.4.7.5. SWOT Analysis
      • 21.4.7.6. Strategy Overview
    • 21.4.8. Shimadzu Corporation
      • 21.4.8.1. Overview
      • 21.4.8.2. Product Portfolio
      • 21.4.8.3. Key Financials
      • 21.4.8.4. Sales Footprint
      • 21.4.8.5. SWOT Analysis
      • 21.4.8.6. Strategy Overview
    • 21.4.9. New England Biolabs.
      • 21.4.9.1. Overview
      • 21.4.9.2. Product Portfolio
      • 21.4.9.3. Key Financials
      • 21.4.9.4. Sales Footprint
      • 21.4.9.5. SWOT Analysis
      • 21.4.9.6. Strategy Overview
    • 21.4.10. Waters.co.
      • 21.4.10.1. Overview
      • 21.4.10.2. Product Portfolio
      • 21.4.10.3. Key Financials
      • 21.4.10.4. Sales Footprint
      • 21.4.10.5. SWOT Analysis
      • 21.4.10.6. Strategy Overview
    • 21.4.11. Merck KGaA
      • 21.4.11.1. Overview
      • 21.4.11.2. Product Portfolio
      • 21.4.11.3. Key Financials
      • 21.4.11.4. Sales Footprint
      • 21.4.11.5. SWOT Analysis
      • 21.4.11.6. Strategy Overview
    • 21.4.12. Palleon Pharmaceuticals
      • 21.4.12.1. Overview
      • 21.4.12.2. Product Portfolio
      • 21.4.12.3. Key Financials
      • 21.4.12.4. Sales Footprint
      • 21.4.12.5. SWOT Analysis
      • 21.4.12.6. Strategy Overview
    • 21.4.13. Asparia Glycomics
      • 21.4.13.1. Overview
      • 21.4.13.2. Product Portfolio
      • 21.4.13.3. Key Financials
      • 21.4.13.4. Sales Footprint
      • 21.4.13.5. SWOT Analysis
      • 21.4.13.6. Strategy Overview
    • 21.4.14. RayBiotech Life,Inc.
      • 21.4.14.1. Overview
      • 21.4.14.2. Product Portfolio
      • 21.4.14.3. Key Financials
      • 21.4.14.4. Sales Footprint
      • 21.4.14.5. SWOT Analysis
      • 21.4.14.6. Strategy Overview
    • 21.4.15. Z Biotech,LLC.
      • 21.4.15.1. Overview
      • 21.4.15.2. Product Portfolio
      • 21.4.15.3. Key Financials
      • 21.4.15.4. Sales Footprint
      • 21.4.15.5. SWOT Analysis
      • 21.4.15.6. Strategy Overview
    • 21.4.16. Chemily Glycoscience
      • 21.4.16.1. Overview
      • 21.4.16.2. Product Portfolio
      • 21.4.16.3. Key Financials
      • 21.4.16.4. Sales Footprint
      • 21.4.16.5. SWOT Analysis
      • 21.4.16.6. Strategy Overview
    • 21.4.17. Lectenz Bio
      • 21.4.17.1. Overview
      • 21.4.17.2. Product Portfolio
      • 21.4.17.3. Key Financials
      • 21.4.17.4. Sales Footprint
      • 21.4.17.5. SWOT Analysis
      • 21.4.17.6. Strategy Overview
    • 21.4.18. 2BScientific
      • 21.4.18.1. Overview
      • 21.4.18.2. Product Portfolio
      • 21.4.18.3. Key Financials
      • 21.4.18.4. Sales Footprint
      • 21.4.18.5. SWOT Analysis
      • 21.4.18.6. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology